United Therapeutics reported $312.5M in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amarin AMRN:US USD -3883000 60.92M
Ardelyx ARDX:US USD -22893000 4.04M
Biogen BIIB:US USD 821M 53.8M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Halozyme Therapeutics HALO:US USD 73.71M 21.78M
Insmed INSM:US USD -130773000 35.63M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Intra Cellular Therapies ITCI:US USD -53507000 33.1M
Johnson & Johnson JNJ:US USD 7.42B 655M
Omeros OMER:US USD -54792000 13.1M
Pfizer PFE:US USD 10.67B 3.11B
Ptc Therapeutics PTCT:US USD -127208000 21.49M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Sangamo Biosciences SGMO:US USD -53125000 10.03M
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Teva Pharmaceutical TEVA:IT USD 768M 1.93B
United Therapeutics UTHR:US USD 312.5M 161.9M